Heart Rhythm TV Pod

Unlocking Antiarrhythmics From ABCs to Action is a new 3-part series designed to strengthen foundational knowledge and support real-world clinical decision-making for allied professionals. From the basics to advanced strategies, this episode breaks down antiarrhythmic drug classes, safety considerations, and how to personalize therapy across diverse patient populations — including the latest on outpatient sotalol and wearable heart monitoring.  #HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Megan Labreck, PharmD, and Rachel Schreier, MSN, ACNP, APRN for a practical, clinically focused discussion to support confident patient care.  Stay tuned for Episodes 2 and 3: Episode 2: Real-World Rhythm — Personalizing AADs Across Populations Episode 3: Wearables and AADs: Next-Gen Rhythm Monitoring at Home Additional Resources https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euaf076/8100306 https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.11.020 https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.10.003 https://www.sciencedirect.com/science/article/pii/S2666501824001478 Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].    

Roderick Tung, MD, FHRS, talks with Amit J. Shanker, MD, FHRS, author of "HRS/ACC scientific statement: Guiding principles on the performance of intracardiac ablation procedures in ambulatory surgical centers", which published in the January 2026 issue of Heart Rhythm.  Additional Resources Article: https://www.heartrhythmjournal.com/article/S1547-5271(25)02874-7/fulltext Issue: https://www.heartrhythmjournal.com/issue/S1547-5271(25)X0013-8 Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

In this episode of Left to Our Own Devices, #HRStv host Oliver J. Monfredi, MBChB, PhD, FHRS is joined by Jurgen Kuschyk, MD, PhD for a clinician-focused introduction to CCM therapy, highlighting key developments, evolving indications, and practical considerations based on 2025 clinical insights and experience. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

The Heart Rhythm Society announced plans to develop a first-of-its-kind Pulsed Field Ablation data collection platform (registry), sponsored in part by Johnson & Johnson MedTech, a global leader in the treatment of heart rhythm disorders. The platform will offer a national, technology-enabled infrastructure designed to advance clinical evidence, improve patient outcomes, and support post-market surveillance for atrial fibrillation PFA procedures. Read the full press release here: https://bit.ly/4qijiQQ Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].

In this new Global EP episode, Prashanthan Sanders, MBBS, PhD, FHRS is joined by Minglong Chen, MD, PhD to highlight exciting developments on PFA in China. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].